4//SEC Filing
Lu Lucy 4
Accession 0001104659-23-001102
CIK 0001429260other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:27 PM ET
Size
5.4 KB
Accession
0001104659-23-001102
Insider Transaction Report
Form 4
Lu Lucy
Executive VP and CFO
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2023-01-01+50,000→ 121,403 total
Footnotes (2)
- [F1]One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the reporting person's termination of service, or earlier upon her death or change in control of the Issuer.
- [F2]The total holdings include 50,000 shares underlying deferred restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001542419
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:27 PM ET
- Size
- 5.4 KB